Abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia in humans, with an estimated lifetime prevalence of 25%. It is characterized by irregular and disorganized electrical ...
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and ...
A material that can shrink to fit around internal organs without crushing them could be used to monitor electrical activity in the body. It contracts to less than half of its initial length when wet, ...
COPENHAGEN, Denmark, Aug. 15, 2023 /PRNewswire/ -- CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab ...
This study sought to study the feasibility, efficacy, and safety of using multiscale entropy (MSE) analysis to guide catheter ablation for persistent atrial fibrillation (PsAF) and predict ablation ...
Data presented suggest that intranasal administration of PH94B to healthy volunteers significantly increased the electrogram response recorded from the nasal mucosa, while rapidly lowering heart rate, ...
Please provide your email address to receive an email when new articles are posted on . The FDA cleared a new electrophysiology recording technology designed to improve signal acquisition and accuracy ...
COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ -- CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, ...
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ -- CathVision, a medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results